Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

AH-001 could be a safer and more effective treatment for hair loss.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

New compounds may soon be tested to treat excessive hair growth in women.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Androgens prevent hair growth by changing Wnt signals in cells.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

5α-reductase inhibitors for hair loss can cause mild, reversible sexual side effects in some men.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.